Local pain management is the most critical aspect of patient care in dentistry. When efforts to achieve local anesthesia are unsuccessful, the resulting stress for both the patient and practitioner can be significant. It is imperative on our part to update our knowledge and skills in using newer alternatives in pain control and management and ways of administering them to increase the comfort level of our patients and resolve the clichéd paradigm of "Pain and Dentistry are inseparable". The improvements in techniques for local anesthesia are probably the most significant advances that have occurred in dental science. This paper provides an update on comparatively newer gadgets that are less commonly used to deliver local anesthetics.
Introduction
Pain has long been associated with dentistry and has a peculiar relation. Pain is the main reason that brings the patient to the dental clinic and also it"s the fear of pain that drives him away especially from receiving non-emergency dental care. So the aim of dental practitioners has always been to successfully render the painless dental care and local anesthesia has been used to achieve this objective. Henceforth, the painless and effective local anesthetic administration has been paramount for any dental surgeon. To accomplish this, every dental surgeon should be critically updated about the newer local anesthetic delivery equipment"s that have been introduced into the market.
I. Computer-Controlled Local Anesthetic Delivery Systems (CCLAD system)

Fig. 1 -Comfort Control Syringe
The pain experienced by the patient is experienced at three junctures i.e. during skin puncture with needle, during local anesthetic deposition and with the acidic pH of the local anesthetic solution which causes local irritation. 1 Numerous attempts have been made to diminish this anesthesia-associated pain, such as by using anesthetic solution patch, chemically modifying anesthetic agents, adding buffering agents, or changing the anesthetic temperature during administration. 1 However, very little attention has been given to the current syringe design and the administration methods, and effectively, syringe systems have changed a little since their introduction. Conventional syringes do not allow precise control of the flow rate, and while slow injections are possible, the mechanics are challenging. 2 Injections into dense tissues such as the palate may require pressures up to 660 psi, possibly making control of a syringe even more difficult, erratic, and uncomfortable.
3 CCLAD System, a pen-like plastic handle, works on eliminates the variability of a thumb-operated plunger, allowing for maintenance of an ideal flow rate of anesthetic 3 . The infusion rate is precisely regulated by a computer processor which immediately compensates for varying tissue resistance encountered in a single injection. The first of these CCLAD devices, the Wand, was introduced in 1997. Several other CCLAD systems are available, including Comfort Control Syringe, QuickSleeper and Anaeject 4, 5, 6 . Both the Comfort Control Syringe and the Anaeject regulate the speed of injection, starting slowly and accelerating the speed of injection to minimize pain. The Comfort Control Syringe has five pre-programmed speeds for different injection techniques and can be used for all injection techniques 4 . The Anaeject has three pre-programmed speeds. Some studies have shown to reduce anxiety as well as pain and pain perception in pediatricand general population with CCLAD system 3, 7, 8, 9, 10, 11, 12, 13 . However D. Ram et el 14 , Versloot J et el 15 and Asarch T 16 et el found no statistical significant difference between conventional injection and a computerized device.
II.
Vibrotactile Devices
Fig. 2(a) -VibraJect
Accupal DentalVibe
Fig. 2(b) -Accupal and DentalVibe
Vibrotactile devices use vibration to reduce the sensation of pain during injections. It takes advantage of the gate control theory of pain management 17, 18 . It has been suggested that when vibration is applied as a counter stimulation to an anesthetic injection, it will reach the brain before the pain sensation does. The brain can perceive only one sensation at a time; therefore, the sensation that arrives at the brain first is the one that will be felt 17, 18, 19, 20 . These devices have shown controversial performance. While Nanitsos et al 20 and Blair 21 have recommended the use of VibraJect for painless injection, M Saijo et el 22 , Roeber B et el 23 and Yoshikawa F et el 24 have found no significant pain reduction when VibraJect. Other devices availabe working on the same principle are Dentalvibe, Syringe Micro Vibrator (smv) and Accupal. Dentalvibe and syringe micro vibrator uses micro-vibration to the site where an injection is being administered while Accupal uses both vibration and pressure 25, 26, 27 . However, there are no good quality studies that have compared these devices with conventional syringes. So their effectiveness is yet to be confirmed by independent sources.
III.
Needless Injector
Fig. 3 -Injex
Needless injector is based on Jet-injection technology which works by creating a high pressure jet of anesthetic solution. 1 This jet of anesthetic solution painlessly or by causing only slight pain can penetrate the mucosal tissue 29 also it is seen to have a lateral spread in the tissue. 30 The degree of penetration in the tissue is a function of volume of anesthetic being used and the nozzle pressure. 31 Researchers also suggest that a layered deposition of anesthetic solution was seen with needle-less injector. 31, 32 The depth of penetration for the volume (0.3ml) used by us is1cm, 31 which would be sufficient enough for giving infiltrations. Directing the jet within the tissues, so that it reaches the foramens is not feasible, thus ruling out the possibility of its use in giving blocks. 31 Difficulty in positioning the device 33 & the need for close tissue contact during deposition of solution using needle-less injector precludes its use posterior region. Only limited volume (0-0.3 ml) of local anesthetic solution can be administered with a single injection 5 29, 33, 35, 37, 38, 39 are quite promising. The needle less jet injector that are available in the market are Injex, Syrijet Mark II and MED-JET H III. The Syrijet Mark II, can accept 1.8ml cartridges of LA solution but permits only 0 to 0.2 mL administrations in single shot 5 . The MED-JET has claimed to have the medication injected with it, penetrates through a small orifice 7 times smaller than the smallest needle on the market.
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IV. Intraosseous Injection Delivery System Fig 4. Intraflow Anesthesia Delivery System
Intraosseous anesthesia involves the placement of local anesthetic directly into the cancellous bone spaces adjacent to the tooth or teeth that require anesthesia. "Intraosseous injection (IOI) can be used as a supplemental or primary technique to bring about local anesthesia in routine dental procedures. It can be used as a supplemental technique with mandibular nerve blocks to enhance deep pulpal anesthesia. It can be used as a primary technique so that patients do not experience numb lips or tongues postoperatively." 43 Devices have been developed to help administer these injections with ease and to overcome the shortcomings of their predecessor.
Stabident, an Intraosseous Injection delivery system has a disadvantage that it can be used in visible and readily accessible area because while giving intraoral injection once the perforator is withdrawn, it can be extremely difficult to locate the perforation site with the anesthetic needle 5 . To overcome this, X-Tip uses the pilot drill which is a hollow tube through which a 27-gauge needle can pass. The initial drill stays in place, allowing the anesthetic to be placed without hunting for the hole that was just created. 4 IntraFlow anesthesia system further ease the IO injection by using a single-step method which allows entry into the penetration zone, injection, and withdrawal in one continuous step, without the need to relocate the perforation site 4 . Reemers et el 44 reported that the IntraFlow system as a primary technique provide reliable anesthesia of posterior mandibular teeth in 13 of 15 subjects, compared to 9 of 15 with an inferior alveolar nerve block. Nussteinet el 45 found supplemental mandibular intraosseous injection using the Stabident system and 1.8 mL of 2% lidocaine with 1:100,000 epinephrine was 88% successful in gaining total pulpal anesthesia for posterior teeth diagnosed with irreversible pulpitis. Parenteet el 46 used the Stabident intraosseous injection in patients with irreversible pulpitis when conventional local anesthetic techniques failed. They found an initial supplemental intraosseous injection was successful in 91% of posterior mandibular teeth. Nussteinet al 47 used an X-tip supplemental intraosseous injection in patients with irreversible pulpitis when a conventional inferior alveolar nerve block failed. They concluded that when the inferior alveolar nerve block fails to provide profound pulpal anesthesia, the X-tip system, when used in an apical location and when there was no backflow of the anesthetic solution into the oral cavity, is successful in achieving pulpal anesthesia in mandibular posterior teeth of patients presenting with irreversible pulpitis. Gallatin 48 et el reported that the primary injection with Stabident intraosseous injection system and a primary X-tip intraosseous injection system were similar regarding the anesthetic success, onset and duration in mandibular posterior teeth but found higher incidence of postoperative swelling.
V. Conclusion
With less number of contradicting studies needle-less injector and CCLAD system appear to be painless in comparison to conventional injection. Effectiveness of vibrotactile devices is controversial on the basis of present data and data available is itself insufficient. Intraosseous devices have shown significantly promising results in achieving supplemental anesthesia. High cost of devices is a setback. More number of randomized controlled trials and cost cutting would guide their future.
